EUVIMEDEUVIMED entdecken
Open Access

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19

Kevin E Kip, Erin K McCreary, Kevin Collins, Tami E Minnier iD, Graham M Snyder iD, William Garrard iD, Jeffrey C McKibben, Donald M Yealy, Christopher W Seymour, David T Huang iD, J Ryan Bariola, Mark Schmidhofer und 4 weitere

Annals of Internal Medicine · 2023

DOI: 10.7326/m22-1286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Kevin E Kip und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (K.E.K., K.C., W.G., J.C.M., O.C.M.). Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansAntibodies, MonoclonalCohort StudiesObservational Studies as TopicRandomized Controlled Trials as TopicPragmatic Clinical Trials as Topic

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (K.E.K., K.C., W.G., J.C.M., O.C.M.).
  • Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (E.K.M., G.M.S., J.R.B.).
  • Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (T.E.M., P.L.K.).
  • Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (D.M.Y., R.J.W.).
  • Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (C.W.S., D.C.A.).
  • Department of Emergency Medicine and Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (D.T.H.).

ORCID-Profile: Tami E Minnier, Graham M Snyder, William Garrard, David T Huang, Richard J Wadas, Derek C Angus, Paula L Kip

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Kip, K. E., McCreary, E. K., Collins, K., Minnier, T. E., Snyder, G. M., Garrard, W., McKibben, J. C., Yealy, D. M., Seymour, C. W., Huang, D. T., Bariola, J. R., Schmidhofer, M., Wadas, R. J., Angus, D. C., Kip, P. L., & Marroquin, O. C. (2023). Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19. Annals of Internal Medicine. https://doi.org/10.7326/m22-1286

Vancouver

Kip KE, McCreary EK, Collins K, Minnier TE, Snyder GM, Garrard W, et al. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19. Annals of Internal Medicine. 2023. doi:10.7326/m22-1286

BibTeX
@article{Kip2023,
  author = {Kip, Kevin E and McCreary, Erin K and Collins, Kevin and Minnier, Tami E and Snyder, Graham M and Garrard, William and McKibben, Jeffrey C and Yealy, Donald M and Seymour, Christopher W and Huang, David T and Bariola, J Ryan and Schmidhofer, Mark and Wadas, Richard J and Angus, Derek C and Kip, Paula L and Marroquin, Oscar C},
  title = {Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19},
  journal = {Annals of Internal Medicine},
  year = {2023},
  doi = {10.7326/m22-1286}
}
Kostenlos starten →